Solving Kids' Cancer

Recent papers from Solving Kids' Cancer

1. Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancerEuropean Journal of Cancer · 2025
2. Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumPediatric Blood & Cancer · 2025
3. A 2035 Clinical Research Vision and Roadmap for High‐Risk NeuroblastomaPediatric Blood & Cancer · 2025
4. Patients, parents and professional perspectives on molecular radiotherapy for neuroblastoma and paediatric neuroendocrine cancersNuclear Medicine Communications · 2025
5. Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationEuropean Journal of Cancer · 2025
6. Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis CancersJAMA Network Open · 2024
7. Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancerEuropean Journal of Cancer · 2024
8. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationEuropean Journal of Cancer · 2023
9. Changing incentives to ACCELERATE drug development for paediatric cancerCancer Medicine · 2023
10. The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory DecisionsJournal of Clinical Oncology · 2022
11. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomasEuropean Journal of Cancer · 2022
12. A systematic literature review to identify ethical, legal, and social responsibilities of nonprofit organizations when funding clinical trials in pediatric cancerPediatric Blood & Cancer · 2022
13. To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastomaPediatric Blood & Cancer · 2022
14. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancerEuropean Journal of Cancer · 2021
15. Intercontinental collaboration in clinical trials for children and adolescents with cancer—A systematic review by ACCELERATECancer Medicine · 2021
16. Bromodomain and extra-terminal inhibitors—A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children—ACCELERATEEuropean Journal of Cancer · 2021
17. Pediatric cancer research: Surviving COVID‐19Pediatric Blood & Cancer · 2020